Search
for
Sort by
Research 691–720 of 1000+
- Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment
- Tinea capitis in Benghazi, Libya
- Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8‐expressing transgenic mice
- Complications of Rhytidectomy
- Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature
- Acute urinary retention: risks and management.
- Skin manifestations of obesity: a comparative study
- Dutasteride
- What Are the Micronutrient Deficiencies Responsible for the Most Common Nutritional Symptoms After Bariatric Surgery?
- Pemphigus Foliaceus in 91 Dogs
- Gefitinib: an adverse effects profile
- Tobacco and the skin
- Intraoperative floppy iris syndrome
- Cutaneous Side Effects of Oral Contraceptives
- Telogen Effluvium: A Review of the Literature
- Transepidermal drug delivery: A new treatment option for areata alopecia?
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Clinical Characteristics and Prognostic Factors in Early-Onset Alopecia Totalis and Alopecia Universalis
- Animal models of androgen-dependent disorders of the pilosebaceous apparatus
- Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice
- Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Cicatricial alopecia secondary to radiation therapy: case report and review of the literature.
- Scalp Seborrheic Dermatitis: What We Know So Far
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- Bimatoprost versus Mometasone Furoate in the Treatment of Scalp Alopecia Areata: A Pilot Study
- Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role
- Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Pathogenesis associated with hair follicle mites (Demodex spp.) in Australian Aborigines